Markets
NewEdge Advisors LLC Purchases 41,950 Shares of Merck & Co., Inc. $MRK
NewEdge Advisors LLC increased its stake in Merck & Co., Inc. by 10.1% in the second quarter, adding 41,950 shares to now own 455,515 shares valued at $58.5 million. Institutional investors collectively own 76.07% of Merck's stock. Despite positive analyst ratings and strong revenue growth, the company faces challenges including the impending patent expiration of Keytruda in 2028 and past weaknesses in Gardasil sales.